Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Social Anxiety Disorder

NCT00294346 is registered in ClinicalTrials.gov with Avera Pharmaceuticals as lead sponsor.

NCT NCT00294346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Social Anxiety Disorder
Lead sponsor
Avera Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
December 31, 2006
Enrollment
180
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

social phobia